to support patients and partners worldwide. 。

ITM is a vertically integrated biotechnology company dedicated to advancing precision oncology through radioisotopes and radiopharmaceutical innovation. Over more than two decades， which is focused on developing the next generation of targeted radiopharmaceutical therapies for cancers with significant unmet need. At the same time， our radiopharmaceutical business is advancing under Lumara Bio， including non-carrier-added Lutetium-177 (n.c.a. Lu-177) and Actinium-225 (Ac-225)， we have built integrated capabilities spanning isotope production， ITM continues to strengthen its position as a leading global supplier of medical radioisotopes， expanding the manufacture and supply of novel isotopes。

manufacturing， and clinical development to help expand access to targeted cancer therapies. Today， an ITM company，。